Table 2 Proportion of patients who were untreated or received, at least one, two, three, or four distinct treatment lines during the entire follow-up period
CCAE (N = 114,543) | MDCD (N = 69,006) | MDCR (N = 5660) | Optum (N = 80,459) | |||||
|---|---|---|---|---|---|---|---|---|
Treatment line | % of all patients | % of treated | % of all patients | % of treated | % of all patients | % of treated | % of all patients | % of treated |
Untreated | 29.5% | 51.9% | 33.5% | 35.9% | ||||
1st | 70.5% | 100% | 48.1% | 100% | 66.5% | 100% | 64.1% | 100% |
2nd | 42.0% | 59.5% | 23.0% | 47.8% | 35.5% | 53.4% | 34.4% | 53.7% |
3rd | 22.3% | 31.6% | 12.0% | 25.0% | 16.7% | 25.1% | 17.1% | 26.7% |
4th | 11.1% | 15.7% | 5.9% | 12.2% | 6.8% | 10.3% | 7.8% | 12.2% |